The International Trade Commission seeks comments by Dec. 1 on a Section 337 complaint alleging that imports of smart rings infringe patents held by Ouraring, it said in a notice to be published Nov. 21 in the Federal Register. According to the complaint, Ouraring is seeking a limited exclusion order and cease and desist orders against Samsung, Reebok, their subsidiaries and seven other companies from the U.K., China, India and the U.S. to bar from entry "certain smart wearable devices, systems, and components thereof" that violate their patents. Ouraring said that its product is a smart ring that "accurately provides personalized insights into user’s fitness and health by monitoring heart rate, temperature variations, blood oxygen levels, and movement during both sleep and active periods."
The International Trade Commission seeks comments by Dec. 1 on a Section 337 complaint alleging that imports of microwave hoods infringe patents held by Whirlpool Corporation, it said in a notice to be published Nov. 21 in the Federal Register. According to the complaint, Whirlpool is seeking a limited exclusion order and cease and desist orders against Samsung and LG Electronics and their subsidiaries, and six U.S.- and Canada-based companies to bar from entry "certain low profile microwave-hood combination products" that violate their patents. Whirlpool said that its products "are designed to fit into the undercabinet hood space above a cooking range, providing a two-in-one kitchen appliance that cooks and provides ventilation."
The International Trade Commission seeks comments by Dec. 1 on a Section 337 complaint alleging that imports of antibody drugs infringe patents held by AbbVie Inc., and ImmunoGen, Inc., it said in a notice to be published Nov. 21 in the Federal Register. According to the complaint, AbbVie is seeking a limited exclusion order and cease and desist orders against ProfoundBio, Genmab and their subsidiaries to bar from entry "certain antibody drug conjugates products and components thereof and products containing the same" that violate their patents. AbbVie said that its product ELAHERE, is "a first-in-class ADC approved to treat adult patients with certain ovarian, fallopian tube, and primary peritoneal cancers."
The International Trade Commission published notices in the Nov. 19 Federal Register on the following antidumping and countervailing duty injury, Section 337 patent or other trade proceedings (any notices that warrant a more detailed summary will be in another ITT article):
The Commerce Department published notices in the Federal Register Nov. 19 on the following antidumping and countervailing duty (AD/CVD) proceedings (any notices that announce changes to AD/CVD rates, scope, affected firms or effective dates will be detailed in another ITT article):
The Commerce Department universally tolled all "Enforcement and Compliance deadlines" for 47 days, the effective length of the federal government shutdown, save for submissions due during the shutdown and requests for administrative reviews of suspension agreements and antidumping and countervailing duty orders.
The International Trade Commission published notices in the Nov. 18 Federal Register on the following antidumping and countervailing duty injury, Section 337 patent or other trade proceedings (any notices that warrant a more detailed summary will be in another ITT article):
The International Trade Commission seeks comments by Nov. 28 on a Section 337 complaint alleging that imports of semiconductor devices infringe patents held by Adeia, it said in a notice to be published Nov. 19 in the Federal Register. According to the complaint, Adeia is seeking a limited exclusion order and cease and desist orders against ADM, Lenovo and Supermicro Computer to bar from entry "certain semiconductor devices, computing products containing the same, and components thereof" that violate their patents. Adeia said in the complaint that "arguments that attempt to label Adeia as a 'troll' or non-practicing entity are baseless."
The International Trade Commission seeks comments by Nov. 28 on a Section 337 complaint alleging that imports of vaporizer devices infringe patents held by Align Technology, it said in a notice to be published Nov. 19 in the Federal Register. According to the complaint, Align Technology is seeking a limited exclusion order and cease and desist orders against U.S. company USA Angelalign Technology Corp., two Chinese companies and their subsidiaries to bar from entry "certain clear aligners and components thereof" that violate their patents. Align said that its product Invisalign "is a series of clear aligners that patients swap out periodically to gradually re-align their teeth."
The Commerce Department published notices in the Federal Register Nov. 18 on the following antidumping and countervailing duty (AD/CVD) proceedings (any notices that announce changes to AD/CVD rates, scope, affected firms or effective dates will be detailed in another ITT article):